bioAffinity Technologies, Inc. completed a public offering on September 29, 2025, raising approximately $4.8 million by selling 1,047,694 shares at $2.50 each and 874,067 Pre-Funded Warrants. This funding aims to bolster working capital and compliance with Nasdaq requirements, enhancing their financial stability.